(:MDSO)

Oct 24, 2019 06:10 pm ET
FTI Consulting Set to Join S&P MidCap 400; KKR Real Estate Finance Trust to Join S&P SmallCap 600
NEW YORK, Oct. 24, 2019 /PRNewswire/ -- S&P SmallCap 600 constituent FTI Consulting Inc. (NYSE: FCN) will replace Medidata Solutions Inc. (NASD: MDSO) in the S&P MidCap 400, and KKR Real Estate Finance Trust Inc. (NYSE: KREF) will replace FTI Consulting in the S&P SmallCap 600 effective prior to the open of trading on Wednesday, October 30.  Dassault Systemes SA is acquiring Medidata Solutions in a transaction expected to be completed on or about that date pending final conditions.
Oct 03, 2019 08:30 am ET
Medidata Introduces Study Site Analytics, New Feature for Sites to Receive Real-Time Performance Metrics and Benchmarks
FDA inspections continue to highlight recurring issues with site performance throughout the past ten years. To prevent performance issues, sites rely on actionable performance information prior to preparing for regulatory inspection. According to a
Oct 02, 2019 08:30 am ET
Forbes Names Medidata CEO to “America’s Most Innovative Leaders” List
Forbes named Tarek Sherif, CEO of Medidata (NASDAQ: MDSO), to their list of “
Sep 17, 2019 08:30 am ET
For Precision Medicine to Achieve Its Potential, Life Science Leaders Embrace New Data and AI Models
Eighty-four percent of senior life science executives agree that precision medicine represents a new era in drug development, according to the Newsweek Vantage report, Precision Medicine: Creating Value for Everyone. Sponsored by
Sep 12, 2019 08:30 am ET
Medidata and Mapi Research Trust (MRT) Announce Strategic Collaboration to Standardize eCOA Global Library of Questionnaires
Medidata (NASDAQ: MDSO) and Mapi Research Trust today announced a new critical mission: to build a digital, global library of pre-configured an
Jul 24, 2019 07:30 pm ET
Rigrodsky & Long, P.A. Files Class Action Suit Against Medidata Solutions, Inc.
Rigrodsky & Long, P.A.: Rigrodsky & Long, P.A. announces that it has filed a class action complaint in the United States District Court for the District of Delaware on behalf of holders of Medidata Solutions, Inc. (“Medidata”) (NASDAQ GS: MDSO)...
Jul 24, 2019 06:48 pm ET
Shareholder Alert: Halper Sadeh LLP Reminds Investors it is Investigating Whether the Sale of These Companies is Fair to Shareholders – SFLY, MDSO, TSS, EE
Halper Sadeh LLP, a global investor rights law firm, reminds investors that it is investigating the following companies: Shutterfly, Inc. (NASDAQ: SFLY) The investigation concerns whether Shutterfly and its board of directors breached their...
Jul 23, 2019 01:00 am ET
Medidata Reports Second Quarter 2019 Results
Medidata (NASDAQ:MDSO) today announced its financial results for the second quarter of 2019.
Jul 15, 2019 12:28 pm ET
SFLY, RTN, OMN AND MDSO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
Rigrodsky & Long, P.A. announces that it is investigating: Shutterfly, Inc. (NASDAQ GS: SFLY) regarding possible breaches of fiduciary duties and other violations of law related to Shutterfly’s agreement to be acquired by affiliates of Apollo...
Jul 12, 2019 04:11 pm ET
INVESTOR RIGHTS ALERT: Halper Sadeh LLP Continues Investigating Whether the Sale of These Companies is Fair to Shareholders; Investors Are Encouraged to Contact the Firm – RTN, SFLY, DATA, MDSO
Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Raytheon Company (NYSE: RTN)The investigation concerns whether Raytheon and/or its Board of Directors breached their fiduciary duties...
Jul 10, 2019 05:44 pm ET
SHAREHOLDER ALERT: WeissLaw LLP Reminds MDSO, BID, and DFRG Shareholders About Its Ongoing Investigations
If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP 1500 Broadway, 16th...
Jul 10, 2019 05:00 pm ET
Medidata Announces Second Quarter 2019 Earnings Date
Medidata (NASDAQ: MDSO) today announced that it will release its second quarter 2019 results after the close of U.S. financial markets on Tuesday, July 23, 2019. Due to the company's pending acquisition by Dassault Systèmes, it will not host a conference call to discuss its results.
Jul 10, 2019 08:30 am ET
Catalyst Launches New Multi-solution CRO Powered by the Medidata Rave Clinical Cloud™
Medidata (NASDAQ: MDSO) announced today that Catalyst Clinical Research chose the Medidata Rave Clinical Cloud™ for its one-platform approach to clinical trials. By adopting Medidata Rave CTMS combined with Rave EDC and Rave eTMF, Catalyst immediately offers a data-driven, state-of-the-art unified clinical platform as it launches its new CRO full-service managed solutions
Jul 02, 2019 08:30 am ET
TissueTech Expands its Clinical Program with Medidata’s End-to-end Unified Platform
Medidata (NASDAQ: MDSO) announced that TissueTech, Inc. has chosen the Medidata Rave Clinical Cloud™ as its end-to-end platform for clinical trials. TissueTech recognizes this partnership as critical to helping spearhead the company’s transformation in biologics with a focus on regenerative therapies derived from human birth tissue for patients with serious unmet clinical
Jun 27, 2019 07:45 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors that it is Investigating the Boards of Directors of Medidata Solutions, Stewardship Financial, C&J Energy Services, and Tableau Software on Behalf of Stoc
Bragar Eagel & Squire, P.C. reminds investors that it is investigating potential claims on behalf of stockholders of Medidata Solutions, Inc., Stewardship Financial Corporation, C&J Energy Solutions, Inc., Tableau Software, Inc. Additional...
Jun 27, 2019 11:01 am ET
ARRY, RTN, DATA and MDSO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
Rigrodsky & Long, P.A. announces that it is investigating: Array BioPharma Inc. (NASDAQ GM: ARRY) regarding possible breaches of fiduciary duties and other violations of law related to Array BioPharma’s agreement to be acquired by Pfizer Inc....
Jun 26, 2019 01:32 pm ET
Legal Investigation Alert: Halper Sadeh LLP is Investigating Whether the Sale of These Companies is Fair to Shareholders – SFLY, DATA, LTXB, MDSO
Halper Sadeh LLP, a global investor rights law firm, is investigating Shutterfly, Inc. (NASDAQ: SFLY), Tableau Software, Inc. (NYSE: DATA), LegacyTexas Financial Group, Inc. (NASDAQ: LTXB), and Medidata Solutions, Inc. (NASDAQ: MDSO) in connection...
Jun 25, 2019 04:20 pm ET
GDI, MDSO and CY SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
Rigrodsky & Long, P.A. announces that it is investigating: Gardner Denver Holdings, Inc. (NYSE: GDI) regarding possible breaches of fiduciary duties and other violations of law related to Gardner Denver’s agreement to merge with Ingersoll-Rand...
Jun 25, 2019 03:32 pm ET
MEDIDATA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Medidata Solutions, Inc. - MDSO
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Medidata Solutions, Inc. (NasdaqGS: MDSO) to Dassault Systèmes. Under the terms of the proposed transaction, shareholders of Medidata will receive only $92.25 in cash for each share of Medidata that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Jun 25, 2019 08:30 am ET
Orion Transforms its Clinical Trials with Medidata
By unifying all required capabilities to deliver a successful clinical trial, the Rave Clinical Cloud has become the platform of choice. It creates a single source of truth for all study-related data. This data-driven approach to clinical study conduct breaks down silos and enables study teams to reuse study data when needed.
Jun 24, 2019 05:57 pm ET
MERGER ALERT – MDSO, LTXB, and BID: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. Medidata Solutions, Inc. (NASDAQGS: MDSO)...
Jun 24, 2019 03:30 pm ET
DATA, MDSO and LTXB SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
Rigrodsky & Long, P.A. announces that it is investigating: Tableau Software, Inc. (NYSE: DATA) regarding possible breaches of fiduciary duties and other violations of law related to Tableau’s agreement to be merge with salesforce.com, inc....
Jun 21, 2019 05:16 pm ET
RTN, SSFN AND MDSO SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Buyouts
Rigrodsky & Long, P.A. announces that it is investigating: Raytheon Company (NYSE: RTN) regarding possible breaches of fiduciary duties and other violations of law related to Raytheon’s agreement to be acquired by United Technologies...
Jun 20, 2019 10:03 am ET
MERGER ALERT – MDSO, SSFN, and DNBF: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. Medidata Solutions, Inc. (NASDAQGS: MDSO)...
Jun 13, 2019 03:25 pm ET
MDSO, EE and DATA SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of Mergers
Rigrodsky & Long, P.A. announces that it is investigating: Medidata Solutions, Inc. (NASDAQ GS: MDSO) regarding possible breaches of fiduciary duties and other violations of law related to Medidata’s agreement to be acquired by Dassault Systemes...
Jun 13, 2019 02:18 pm ET
MERGER ALERT – MDSO, SSFN, and DATA: Levi & Korsinsky, LLP Reminds Investors of Investigations Concerning the Sale of these Companies
The following statement is being issued by Levi & Korsinsky, LLP: Levi & Korsinsky, LLP announces that investigations have commenced on behalf of shareholders of the following publicly-traded companies. Medidata Solutions, Inc. (NASDAQGS:...
Jun 12, 2019 07:04 pm ET
Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of Medidata Solutions (NASDAQ: MDSO) on Behalf of Medidata Shareholders and Encourages Medidata Investors to Contact the Firm
Bragar Eagel & Squire, P.C. is investigating potential claims against the board of directors of Medidata Solutions (NASDAQ: MDSO) on behalf of Medidata shareholders concerning the proposed merger with Dassault Systèmes (Other OTC: DASTY). Click...
Jun 12, 2019 10:34 am ET
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Medidata Solutions, Inc. to Dassault Systèmes is Fair to Shareholders
The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Medidata Solutions, Inc. (“Medidata” or the “Company”) (NASDAQGS: MDSO) stock prior to June 12, 2019. You are hereby notified that Levi &...
Jun 12, 2019 09:35 am ET
MEDIDATA SOLUTIONS, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Buyout
Rigrodsky & Long, P.A.: Do you own shares of Medidata Solutions, Inc. (NASDAQ GS: MDSO)? Did you purchase any of your shares prior to June 12, 2019?Do you think the proposed buyout is fair?Do you want to discuss your rights?  Rigrodsky & Long,...
Jun 12, 2019 08:47 am ET
Medidata Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Sale of Medidata Solutions, Inc. is Fair to Shareholders – MDSO
Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Medidata Solutions, Inc. (“Medidata” or the “Company”) (NASDAQ: MDSO) to Dassault Systèmes (“Dassault”) is fair to Medidata shareholders. On behalf of...
Jun 12, 2019 01:00 am ET
Dassault Systèmes and Medidata Solutions To Join Forces To Accelerate the Life Sciences Industry Innovation For Patient-Centric Experience Through End-to-End Collaborative Platform
Dassault Systèmes (Euronext Paris: #13065, DSY.PA) and Medidata Solutions, Inc. (NASDAQ: MDSO), leader of the digital transformation of the Life Sciences industry for clinical development, commercial, and real-world data intelligence, today announced the signing of a definitive agreement for Dassault Systèmes to acquire Medidata i
Jun 03, 2019 08:30 am ET
Medidata Institute Redefines Technology’s Role in Advancing Science and Healthcare
Medidata (NASDAQ:MDSO) announced today that the Medidata Institute is working with industry partners to deliver insights that redefine how technology, data and AI can improve lives and inspire the next generation of medical treatments.
May 31, 2019 06:37 pm ET
Medidata Recognized as the Only Company to be Both a Leader and Star Performer in Everest Group’s 2019 Life Sciences Clinical Trials Products PEAK Matrix™
Medidata (NASDAQ:MDSO) announced today that it has been named a Leader in the Everest Group’s 2019 Life Sciences Clinical Trials Products PEAK Matrix, based upon market impact, plus vision and capability. Medidata was also recognized as a Star Performer, which designates the greatest positive relative year-on-year movement on the PEAK
May 30, 2019 05:30 pm ET
Medidata to Present at Jefferies Healthcare Conference
Medidata (NASDAQ: MDSO) today announced that Rouven Bergmann, chief financial officer, will present at the Jefferies 2019 Healthcare Conference on Thursday, June 6, 2019, at 9 a.m. ET in New York.
May 13, 2019 08:30 am ET
Medidata’s Jackie Kent and Katrina Weigold Honored by the Healthcare Businesswomen’s Association
Medidata (NASDAQ:MDSO) is pleased to announce that Jackie Kent was named a “Luminary” and Katrina Weigold a “Rising Star” by the Healthcare Businesswomen’s Association (HBA). Both executives were recognized at the
May 09, 2019 08:30 am ET
Medidata to Present at J.P. Morgan Global Technology, Media and Communications Conference
Medidata (NASDAQ: MDSO) today announced that Tarek Sherif, chairman and chief executive officer, will present at the 47th Annual J.P. Morgan Technology, Media and Communications Conference on Tuesday, May 14, 2019, at 2 p.m. ET in Boston.
May 03, 2019 08:30 am ET
Medidata’s Corporate Social Responsibility Program Wins Gold Stevie® Award
Medidata (NASDAQ: MDSO) won a Gold Stevie Award in the ‘Corporate Social Responsibility Program of the Year’ category at the 17th Annual American Business Awards.
May 01, 2019 08:30 am ET
Smith & Nephew Adopts One-platform Approach with Medidata to Support Expansion of Study Portfolio
Medidata (NASDAQ: MDSO) today announced that medical technology business Smith & Nephew (LSE: SN, NYSE: SNN) has consolidated all of its global studies on the Medidata Rave Clinical Cloud. The company expanded its use of Rave clinical solutions and will leverage Medidata Managed Services to design and implement studies globally.
Apr 30, 2019 06:30 am ET
Medidata Reports First Quarter 2019 Results
Medidata (NASDAQ: MDSO) today announced its financial results for the first quarter of 2019.
Apr 29, 2019 08:30 am ET
Medidata Corporate Social Responsibility Initiatives Recognized for Global Sustainability, Diversity and Equality in the Workplace
Medidata (NASDAQ: MDSO) corporate social responsibility (CSR) and diversity and belonging programs continue to earn honors as they make a difference for patients, employees, and the environment.
Apr 16, 2019 08:30 am ET
Medidata Announces First Quarter 2019 Earnings Conference Call
Medidata (NASDAQ:MDSO) today announced that it will release its first quarter 2019 financial results before the market opens on Tuesday, April 30, 2019. The company will also hold a conference call at 8 a.m. ET for the investment community to discuss the company’s results.
Apr 11, 2019 06:30 am ET
Medidata Launches Acorn AI™ and Appoints Dr. Rama Kondru as CIO
Medidata Solutions (NASDAQ: MDSO) is taking the next significant step to accelerate the digital transformation of life sciences in the age of precision medicine. Today, Medidata is launching Acorn AI, a Medidata company, and appoints Rama Kondru, Ph.D., as the chief information officer for Medidata.
Mar 27, 2019 07:00 am ET
Research Report Identifies Alamos Gold, Thermo Fisher Scientific, Veracyte, Air Lease, Carlisle Companies, and Medidata Solutions with Renewed Outlook — Fundamental Analysis, Calculating Forward Movem
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Alamos Gold Inc. (NYSE:AGI), Thermo Fisher Scientific Inc. (NYSE:TMO),...
Feb 28, 2019 08:30 am ET
SHYFT Expands Real-World Evidence Solutions Empowering Life Sciences to Make Better Value-Based Decisions
SHYFT Analytics, a Medidata company (NASDAQ: MDSO), today announced that it has significantly enhanced the real-world evidence (RWE) components of its solution platform. This expansion includes the appointment of key leadership positions that allow the company to cater to a broader range of life science organizations, includin
Feb 19, 2019 08:30 am ET
Medidata to Present at Upcoming Investor Conferences
Medidata (NASDAQ: MDSO) today announced its participation in two upcoming investor conferences.
Feb 12, 2019 06:30 am ET
Medidata Reports Fourth Quarter 2018 Results
Medidata (NASDAQ:MDSO) today announced its financial results for the fourth quarter of 2018.
Feb 11, 2019 04:35 pm ET
Medidata and Cognizant Form Strategic Alliance to Make Digital Transformation Accessible for the Life Sciences
Medidata (NASDAQ:MDSO) and Cognizant (NASDAQ:CTSH) have entered into a strategic alliance to offer life science clients comprehensive solutions that leverage the market’s leading
Feb 01, 2019 07:20 am ET
Report: Developing Opportunities within Medidata Solutions, National Instruments, A10 Networks, Cal-Maine Foods, Century Communities, and Resonant — Future Expectations, Projections Moving into 2019
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Medidata Solutions, Inc. (NASDAQ:MDSO), National Instruments Corporation...
Jan 29, 2019 08:30 am ET
Medidata Announces Fourth Quarter 2018 Earnings Conference Call
Medidata (NASDAQ: MDSO) today announced that it will release its fourth quarter 2018 financial results before the market opens on Tuesday, February 12, 2019. The company will also hold a conference call at 8 a.m. ET for the investment community to discuss the company’s results and business outlook.
Jan 23, 2019 08:30 am ET
Medidata Joins the World Economic Forum
Medidata (NASDAQ:MDSO) today announced that it has entered into a three-year strategic collaboration with the World Eco
Jan 22, 2019 05:30 pm ET
Medidata Introduces New Collaborative Workspace for Sites, Sponsors, and CROs to Manage TMF Content
Over 35 percent of inspections are delayed because the TMF is not complete or readily available1. To enable efficient, real-time collaboration on TMF documents between sponsors, CROs and sites, Medidata (NASDAQ:MDSO) today introduced a new workspace feature of its eTMF solution.
Jan 18, 2019 08:30 am ET
Medidata Named Best Workplace in Technology by Great Place to Work® and FORTUNE
Great Place to Work and FORTUNE named Medidata (NASDAQ:MDSO) one of the 2019 Best Workplaces in Technology. The company was selected 25th among large companies.
Jan 07, 2019 04:49 pm ET
Medidata Appoints Industry Leader Sastry Chilukuri as Executive Vice President of Digital and AI Solutions
Medidata (NASDAQ:MDSO) today announced the addition of executive vice president of Digital and AI Solutions, Sastry Chilukuri to its senior leadership team.
Dec 27, 2018 08:30 am ET
Medidata to Present at the 37th Annual J.P. Morgan Healthcare Conference
Medidata (NASDAQ:MDSO) today announced that Tarek Sherif, chairman and chief executive officer, and Rouven Bergmann, chief financial officer, will present at the 37th Annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 9, 2019, in San Francisco at 4 p.m. PT (7 p.m. ET).
Dec 18, 2018 08:30 am ET
Cala Health Streamlines Data and Operational Management for Neurological Device Study with Medidata Cloud
Medidata (NASDAQ:MDSO) today announced that Cala Health, a neuromodulation platform company developing wearable therapies for chronic disease, is adopting the Medidata Cloud to centralize management of a large observational study.
Dec 13, 2018 08:30 am ET
No Need for End of Study CDs: Medidata Introduces NEW Rave Digital EOS Media Delivery
To ease and unify Rave End of Study (EOS) document management, Medidata (NASDAQ:MDSO) today introduced a new, automated function of Edge Regulatory Content Management (RCM). Triggered automatically from Rave EDC, the new Edge RCM feature organizes, distributes and retains EOS documents to mainta
Dec 06, 2018 07:55 am ET
Detailed Research: Economic Perspectives on AT&T, JD, EMC Insurance Group, Insys Therapeutics, Medidata Solutions, and Heritage-Crystal Clean — What Drives Growth in Today's Competitive Landscape
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of AT&T Inc. (NYSE:T), JD.com, Inc. (NASDAQ:JD), EMC Insurance Group Inc....
Dec 04, 2018 08:30 am ET
Medidata Rave Omics Collaboration Uncovers Novel Insights for Rare Disease Research
The Castleman Disease Collaborative Network (CDCN) discovered new patient subgroups, based on previously unknown proteomic signatures, with Medidata’s Rave Omics, a machine learning-based solution. These discoveries provide novel insights into treatment response and potential new drug targets, highlighting the value of precision medicine.
Nov 30, 2018 08:45 am ET
Medidata Rave Engage Wins Scrip Award for Best Sponsor-Focused Technological Development in Clinical Trials
Medidata (NASDAQ:MDSO) is pleased to announce that Rave Engage was recognized at the 2018 Scrip Awards as the "Best Technological Development in Clinical Trials - Tech Sponsor Focused." This marks the third consecutive
Nov 29, 2018 08:30 am ET
Federal Court Rejects Veeva’s Attack on Medidata’s Theft of Trade Secret Claims
The United States District Court for the Southern District of New York has rejected Veeva’s motion to dismiss Medidata’s complaint against Veeva for theft of trade secrets, the company announced today.
Nov 21, 2018 08:36 am ET
Medidata to Present at Upcoming Investor Conferences
Medidata (NASDAQ:MDSO) today announced its participation in two upcoming investor conferences.
Nov 20, 2018 08:30 am ET
Two Research Studies Supported by Medidata to be Presented at ASH 2018
The Castleman Disease Collaborative Network (CDCN) will present results of a large-scale proteomics study of idiopathic multicentric Castleman disease (iMCD), supported by Medidata Rave Omics, at the 60th Annual Meeting of the American Society of Hematology. The CDCN will also share an overview of its poster presentation and abstract at the Medida
Nov 15, 2018 08:30 am ET
Hengrui Pharma Partners with Medidata to Accelerate Global Drug Research
Medidata (NASDAQ: MDSO) announced that Hengrui Pharma, one of China’s largest sponsors, recently adopted Medidata Cloud, the Intelligent Platform for Life Sciences, to accelerate global drug research.
Nov 08, 2018 08:30 am ET
PAREXEL and SHYFT Analytics Partner to Deliver Faster, More Dynamic Real-World Data Studies
SHYFT Analytics, a Medidata Solutions (NASDAQ:MDSO) company, and PAREXEL International, a leading innovator of global biopharmaceutical services, today announced that the companies have entered into a strategic partnership that establishes SHYFT’s technology as an integral part of PAREXEL’s foundation for Real-World Evidence (RWE
Nov 07, 2018 06:30 am ET
ERYTECH Expands Use of Medidata Cloud to Centrally Manage All Data for Oncology Trials
Medidata (NASDAQ: MDSO) today announced that ERYTECH (Euronext: ERYP - Nasdaq: ERYP) expanded its use of the Medidata Cloud, the Intelligent Platform for Life Sciences, to streamline clinical trial operations. The addition to Rave EDC of Rave RTSM, Rave Imaging, and Edge Site Payments will allow ERYTECH to improve trial site budgeting, p
Oct 29, 2018 07:55 am ET
Research Report Identifies Box, Southwest Gas, Medidata Solutions, iRobot, American Equity Investment Life Holding, and Abercrombie & Fitch with Renewed Outlook — Fundamental Analysis, Calculating For
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Box, Inc. (NYSE:BOX), Southwest Gas Corporation (NYSE:SWX), Medidata...
Oct 25, 2018 07:22 pm ET
Medidata Honors 2018 Architects of Hope Award Winners
Medidata (NASDAQ:MDSO) today announced the winners of the third annual Architects of Hope Awards. Eight companies were recognized for their innovative approaches to addressing global patient needs at the conclusion of the Medidata NEXT NYC customer and partner conference.
Oct 24, 2018 08:30 am ET
Pharm-Olam Unifies Data on Medidata Cloud, Eliminating Silos
Today at NEXT NYC, Medidata (NASDAQ:MDSO) announced that Pharm-Olam International (Pharm-Olam) signed a new, five-ye
Oct 23, 2018 06:10 pm ET
Medidata Sets Major New Corporate Social Responsibility (CSR) Commitments
Medidata (NASDAQ: MDSO) is committed to creating a better world for patients. The company spent the past year building a corporate social responsibility program dedicated to STEM education, patient advocacy and global inclusion. Today Medidata announces several new pledges to further its
Oct 23, 2018 08:30 am ET
Dr. Jill Biden, National Minority Quality Forum, Global Sponsors and CROs Discuss the Future of Healthcare and Clinical Research at Medidata NEXT NYC 2018
Medidata NEXT NYC, the premier conference on the digital transformation of life sciences, will feature keynotes from global sponsors and CROs, and
Oct 22, 2018 05:30 pm ET
Medidata Appoints Dr. Maria Rivas to its Board of Directors
Medidata (NASDAQ: MDSO) announced today that it has appointed Dr. Maria Rivas to its Board of Directors. An endocrinologist with extensive experience as a senior leader in the pharmaceutical industry, Dr. Rivas becomes the first woman to serve on the company’s board. This also marks her first public board appointment.
Oct 18, 2018 06:30 am ET
Medidata Reports Third Quarter 2018 Results
Medidata (NASDAQ:MDSO) today announced its financial results for the third quarter of 2018.
Oct 17, 2018 08:30 am ET
Medidata to Host Investor Day on October 24 in New York
Medidata (NASDAQ:MDSO) today announced that it will hold its Investor Day on October 24, 2018 in New York.
Oct 10, 2018 08:30 am ET
Medidata Cloud Securely Manages Echocardiogram Images for Global Heart Measurement Study
Medidata (NASDAQ:MDSO) today announced that Medidata Cloud, the Intelligent Platform for Life Sciences, is streamlining the management of medical images for the World Alliance of Societies of Echocardiography (WASE) Normal Values Study. WASE is the first study of its kind to measure heart dimension and function across countries, geograph
Oct 04, 2018 06:24 pm ET
Industry Milestone: Over 15,000 Studies Have Run on Medidata Cloud Platform
More than 15,000 studies have been conducted on the Medidata Cloud, the Intelligent Platform for Life Sciences, Medidata (NASDAQ: MDSO) announced today, making it the industry’s largest data repository.
Oct 04, 2018 08:30 am ET
Medidata Announces Third Quarter 2018 Earnings Conference Call
Medidata (NASDAQ: MDSO) today announced that it will release its third quarter 2018 financial results before the market opens on Thursday, October 18, 2018. The company will also hold a conference call at 8 a.m. ET for the investment community to discuss the company’s results and business outlook.
Oct 04, 2018 07:40 am ET
Report: Exploring Fundamental Drivers Behind MBIA, Heritage Insurance, First American, Medidata Solutions, A. O. Smith, and Magellan Midstream Partners — New Horizons, Emerging Trends, and Upcoming De
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of MBIA, Inc. (NYSE:MBI), Heritage Insurance Holdings, Inc. (NYSE:HRTG),...
Sep 26, 2018 08:30 am ET
Medidata and Decibel Therapeutics Announce Multi-Year Collaboration in Support of Clinical Development for Hearing Loss, Tinnitus, and Balance Disorders
Medidata (NASDAQ:MDSO) today announced that Decibel Therapeutics is adopting Medidata Cloud, the Intelligent Platform for Life Sciences. The agreement will support the Boston biotech company’s clinical development for hearing loss, tinnitus, and balance disorders.
Sep 18, 2018 08:30 am ET
Medidata Certified as a Great Place to Work®
Medidata employees take great pride as “Medidatians,” according to the 2018 Great Place to Work® survey. This is the third consecutive year that Medidata (NASDAQ: MDSO) was
Aug 28, 2018 08:30 am ET
Medidata to Present at Upcoming Investor Conferences
Medidata (NASDAQ: MDSO) today announced its participation in two upcoming investor conferences.
Aug 23, 2018 05:30 pm ET
Hanmi to Streamline Clinical Trials and Bolster Quality of Results with Medidata Cloud
Hanmi expanded its use of the Medidata Cloud, the Intelligent Platform for Life Sciences, to improve clinical trial efficiency and quality of results, Medidata (NASDAQ:MDSO) announced today. By adding Edge Central Monitoring and Rave eCOA/ePRO to its current use of Rave EDC, Hanmi will gain greater insight into clinical trial performance
Aug 23, 2018 08:35 am ET
Medidata Selected for Fortune 100 Fastest-Growing Companies List
In recognition of three record-performing years, Medidata (NASDAQ: MDSO) was selected for Fortune’s 100 Fastest-Growing Companies list. Fortune ranked
Jul 26, 2018 08:50 am ET
Medidata Corporate Social Responsibility Initiatives Benefit Patients, Students, and Communities
Making a difference in the lives of patients and the global community is in Medidata’s (NASDAQ:MDSO) DNA. The company’s ongoing
Jul 24, 2018 06:30 am ET
Medidata Reports Second Quarter 2018 Results
Medidata (NASDAQ: MDSO) today announced its financial results for the second quarter of 2018.
Jul 24, 2018 04:00 am ET
Novartis Partners with SHYFT to Support its Digital Transformation
SHYFT Analytics, a Medidata Solutions (NASDAQ:MDSO) company, announced today that Novartis has selected its I
Jul 11, 2018 05:58 pm ET
Medidata NEXT Seoul and Shanghai Events Host Industry Thought Leaders at the Forefront of the Digital Transformation in Life Sciences
This week, the Asia Pacific segment of Medidata’s (NASDAQ:MDSO) global NEXT series continues with customer events in Seoul and Shanghai. Sessions will explore trends in virtual trials, mobile healthcare, real-world evidence, artificial intelligence, and machine learning.
Jul 10, 2018 08:30 am ET
Medidata Schedules Second Quarter Earnings Conference Call for July 24, 2018
Medidata (NASDAQ:MDSO), today announced that it will release its second quarter 2018 financial results before the open of the market on Tuesday, July 24, 2018. The Company will also hold a conference call at 8:00 a.m. ET for investors and analysts to discuss the Company’s results and business outlook.
Jun 28, 2018 08:30 am ET
Medidata Appoints New China GM and Doubles Size of Talent in Region
With China based customers doubling in 2017, Medidata (NASDAQ: MDSO) announced the appointment of Jim (Hui) Xu as general manager in the market, and plans to double the size of local talent. Recent regulatory changes in China are promoting faster drug approvals, and large sponsors and partners such as Fosun Pharma, BeiGene, and WuXi CDS are joining the
Jun 28, 2018 08:30 am ET
Report: Exploring Fundamental Drivers Behind Health Insurance Innovations, M/I Homes, Deckers Outdoor, Evertec, Medidata Solutions, and REV Group — New Horizons, Emerging Trends, and Upcoming Developm
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Health Insurance Innovations, Inc. (NASDAQ:HIIQ), M/I Homes, Inc....
Jun 25, 2018 08:30 am ET
Clinical Research Can Now Be Truly Patient-Centric By Quantifying Patient Burden with Medidata
To make clinical research truly patient-centric, Medidata (NASDAQ: MDSO) announced the launch of the Patient Burden Index (PBI) on the Medidata Cloud, the Intelligent Platform for Life Sciences. PBI empowers sponsors and CROs to identify and address high-burden procedures and visits that can impact patient participation and retention in a
Jun 12, 2018 06:30 am ET
Medidata Defines the Future of Life Sciences with Acquisition of SHYFT Analytics
Medidata (NASDAQ:MDSO) today announced that it has entered into a definitive agreement to acquire SHYFT Analytics
May 23, 2018 08:30 am ET
Major Cancer Center Further Advances Oncology Research by Integrating Genomic Data Into Medidata's eClinical Platform
Medidata (NASDAQ: MDSO) announced that Memorial Sloan Kettering Cancer Center (MSK) is using Rave Omics with Biomarker Discovery for patients with pancreatic cancer, an example of the paradigm shift in clinical trials through the systematic capture of genomic data and the application of artificial intelligence algorithms. In doing so, MSK aims to obtain further actionable insights from the industry’s only unified eClinical platform, the
May 21, 2018 08:40 am ET
Medidata to Showcase Rave Omics with Biomarker Discovery in Oncology Research at Industry Expert Theater Presentation
For the second consecutive year, Medidata (NASDAQ:MDSO) will be presenting its pioneering analytics innovation during the 2018 ASCO Annual Meeting. The hour-long “Industry Expert Theater” session*, Integration of Genomics Data and Analysis in Oncology Research, will occur on June 2 at 9:30 AM CDT at the Oncology Professionals Hall
May 17, 2018 08:30 am ET
PhaseBio Pharma Becomes Medidata’s 1,000th Customer, Making Company First in Industry to Achieve This Milestone
Biotech company, PhaseBio Pharmaceuticals, has become Medidata’s (NASDAQ:MDSO) 1,000th customer. Medidata is the first and only eClinical company to achieve this milestone. PhaseBio intends to use the Medidata Clinical Cloud® for the initial Phase I study of its newest clinical development program for treatment o
May 15, 2018 08:15 am ET
Report: Exploring Fundamental Drivers Behind Gartner, F5 Networks, Medidata Solutions, Evertec, Ring Energy, and AGCO — New Horizons, Emerging Trends, and Upcoming Developments
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Gartner, Inc. (NYSE:IT), F5 Networks, Inc. (NASDAQ:FFIV), Medidata...
May 14, 2018 05:30 pm ET
Medidata Holds Global Heart Health Awareness Week to Encourage Employee Wellness
Heart disease is the leading cause of death for both men and women. In partnership with the American Heart Association, Medidata (NASDAQ:MDSO) is holding its first annual ‘Global Heart Health Awareness’ week to provide employees around the world with activities that inspire healthier living. Medidata is dedicated to supporting both its e
May 10, 2018 08:30 am ET
Medidata to Present at the 46th Annual J.P. Morgan Global Technology, Media and Communication Conference
Medidata (NASDAQ:MDSO) today announced that Tarek Sherif, chairman and chief executive officer, will present at the 46th Annual J.P. Morgan Global Technology, Media and Communication Conference on Wednesday, May 16, 2018, at 3:00 p.m. ET in Boston, Mass.
May 08, 2018 08:32 am ET
Medidata Offers Breakthrough to De-Risk Clinical Trial Submissions
To help organizations mitigate the risk of regulatory non-approval and delays, Medidata Solutions (NASDAQ:MDSO) is transforming how clinical trial data is validated prior to FDA submission with Edge Trial Assurance.
May 03, 2018 05:30 pm ET
Medidata’s Melinda Pautsch Named a “Rising Star” by the Healthcare Businesswomen’s Association
Medidata (NASDAQ: MDSO) is pleased to announce that its director of strategic accounts and medical device/diagnostic sales, Melinda Pautsch, has been named a 2018 “Rising Star” by the
May 02, 2018 06:10 pm ET
Medidata to Present at Jefferies 2018 Global Technology Conference
Medidata (NASDAQ: MDSO) today announced that Rouven Bergmann, chief financial officer, will present at the Jefferies 2018 Global Technology Conference on Wednesday, May 9, 2018, at 2:30 p.m. PT (5:30 p.m. ET) in Beverly Hills, Calif.
May 01, 2018 08:30 am ET
Idera Pharmaceuticals Increases Operational Efficiency of Global Oncology Program with Medidata Clinical Cloud
Medidata (NASDAQ:MDSO) today announced that Idera Pharmaceuticals, Inc. (NASDAQ:IDRA), expanded its use of the
Apr 27, 2018 08:30 am ET
Medidata Edge Strategic Monitoring Wins “Best Sponsor-Focused Technological Development” at CARE Awards 2018
Medidata (NASDAQ: MDSO) is pleased to announce that its risk based monitoring solution,
Apr 24, 2018 08:42 am ET
Life Science Leaders Discuss Future of Drug Development at Medidata NEXT London
Medidata (NASDAQ: MDSO) is hosting the final European NEXT conference in London this week, with executives presenting from Novartis, aparito, and the global life sciences community. The event will feature discussions on the EU’s General Data Protection Regulation (GDPR), precision medicine, and how digital innovation is enabling the future
Apr 19, 2018 06:30 am ET
Medidata Reports First Quarter 2018 Results
Medidata (NASDAQ:MDSO) today announced its financial results for the first quarter of 2018.
Apr 05, 2018 05:30 pm ET
Medidata Schedules First Quarter Earnings Conference Call for April 19, 2018
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its first quarter 2018 financial results before the open of the market on Thursday, April 19, 2018. The Company will also hold a conference call at 8:00 a.m. ET for investors and analysts
Apr 03, 2018 08:00 pm ET
Australia NHMRC Clinical Trials Centre Partners with Medidata to Digitize Cancer Research
Medidata (NASDAQ: MDSO) announced that the National Health and Medical Research Council Clinical Trial Centre (NHMRC CTC), University of Sydney, will now use Medidata’s unified platform and analytics for all major new studies starting in 2018.
Mar 28, 2018 08:30 am ET
Life Science Leaders Gather at Medidata NEXT Basel and Frankfurt to Examine New Opportunities to Improve Clinical Development and Better Patient Lives
Medidata (NASDAQ:MDSO) successfully hosted NEXT conferences in Basel and Frankfurt, with executives from global life sciences and pharmaceutical companies presenting, including Bayer, Cancer Research UK, and Roche. The conferences featured discussions on precision medicine, the digital era and managing big data in life sciences, artificial
Mar 15, 2018 08:44 am ET
How Do Technology and Data Accelerate Precision Medicine in Oncology? Industry Experts to Discuss During Medidata Webinar
Oncology is leading the precision medicine revolution, as clinical researchers leverage and identify biomarkers to target patient subsets with more effective treatments, and the promise of improving Phase I success rate probability by three times (25.9% versus 8.4%)1. Despite these advancements, the industry continues to struggle with issues arising from the increase in clinical complexity and patient scarcity for precision trials. To discuss these challenges and new opportunities,
Feb 21, 2018 08:30 am ET
Medidata to Present at Morgan Stanley Technology, Media & Telecom Conference
Medidata (NASDAQ:MDSO) today announced that Tarek Sherif, chief executive officer, and Rouven Bergmann, chief financial officer, will present at the Morgan Stanley Technology, Media & Telecom Conference on Wednesday, February 28, 2018, at 11:15 a.m. PT (2:15 p.m. ET) in San Francisco.
Feb 20, 2018 08:30 am ET
Santen Pharmaceutical to Leverage Medidata Edge CTMS to Drive Future Growth in Ophthalmic Clinical Development
Santen Pharmaceutical Co., Ltd, is expanding its use of the Medidata Clinical C
Feb 15, 2018 08:30 am ET
Medidata and eClinical Solutions LLC Mark 10-Year Anniversary Milestone With Expansion Agreement to Adopt Medical Imaging and Workflow Solutions
Medidata (NASDAQ: MDSO) today announced that eClinical Solutions LLC, an industry-leading provider of end-to-end da
Feb 14, 2018 08:30 am ET
Medidata Named One of 100 Most Sustainable Companies in the U.S. by Barron's Magazine
Medidata (NASDAQ:MDSO) has been named to Barron’s first annual list of the “
Feb 13, 2018 05:30 pm ET
Aperio Adds Medidata Edge eTMF and CTMS in Expansion Agreement
Aperio, a leading clinical research organization (CRO) formerly known as iNNO Clinical Outcomes, has expanded its use of the Medidata Clinical Cloud ® platform to include
Feb 13, 2018 08:30 am ET
Medidata Introduces New Edge Family of Products for Clinical Operations at SCOPE 2018
As clinical trials become more complex, sponsors and contract research organizations (CROs) are looking for a unified platform to help them overcome challenges such as dealing with disparate systems, complying with new regulatory requirements and managing an increasing variety and volume of data.
Feb 13, 2018 07:35 am ET
Research Report Identifies Penske Automotive Group, United Natural Foods, American Equity Investment Life Holding, Control4, Nevro, and Medidata Solutions with Renewed Outlook — Fundamental Analysis,
NEW YORK, Feb. 13, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Penske Automotive Group, Inc. (NYSE:PAG), United...
Feb 12, 2018 06:00 am ET
Medidata Solutions to Host Annual European NEXT Conference Series
Medidata Solutions (NASDAQ:MDSO), is pleased to announce the 13th annual NEXT Conference series will commence in Europe in March 2018, with events in Basel (March 7), Frankfurt (March 21) and London (April 25-26). Industry experts in drug and device development, clinical operations, data management, biostatistics and
Feb 08, 2018 06:35 am ET
Medidata Ushers in Era of Choice as Life Science Companies Can Now Conduct Both Virtual and On-site Clinical Trials on One eClinical Platform
Medidata (NASDAQ:MDSO) announced today that its virtual trials platform, Engage, is now being offered as a part of the Medidata Clinical Cloud®, providing researchers unmatched flexibility to conduct clinical trials virtually, on-site, or as a hybrid.
Feb 08, 2018 06:30 am ET
Medidata Reports Record Full-Year and Fourth Quarter 2017 Results
Medidata (NASDAQ:MDSO) today announced its financial results for the fourth quarter and full year 2017 and provided detailed financial guidance for the full year 2018.
Feb 08, 2018 06:00 am ET
Medidata Solutions, Inc. to Host Earnings Call
NEW YORK, NY / ACCESSWIRE / February 8, 2018 / Medidata Solutions, Inc. (NASDAQ: MDSO) will be discussing their earnings results in their Q4 Earnings Call to be held on February 8, 2018 at 8:00 AM Eastern Time.
Feb 06, 2018 08:37 am ET
Medidata’s Next Generation Site Selection and Operational Benchmarking Tools Generally Available
Targeted therapies create new opportunities for patients, but can require complex trial design to achieve their promise. These studies highlight the importance of working with the best clinical trial sites, and managing enrollment and key operational performance indicators (KPIs) in clinical development. Furthermore, regardless of study complexity, sponsors and CROs can struggle finding up-to-date, objective, quantitative sources of data on site performance and operational metrics, both within their organizations and across the industry.
Jan 31, 2018 08:00 am ET
Medidata and Syapse Announce Partnership to Bring Oncology Clinical Trials Into Precision Medicine Era
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, and Syapse, a market leader in precision medicine solutions, have announced a new partnership to transform oncology clinical trials for the age of precision medicine.
Jan 31, 2018 07:00 am ET
Medidata and Syapse Announce Partnership to Bring Oncology Clinical Trials into Precision Medicine Era
NEW YORK and SAN FRANCISCO, Jan. 31, 2018 /PRNewswire/ -- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, and Syapse, a market leader in precision medicine solutions, have announced a new partnership to transform oncology clinical trials for the age of precision medicine.
Jan 25, 2018 08:30 am ET
Medidata Schedules Fourth Quarter Earnings Conference Call for February 8, 2018
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its fourth quarter 2017 financial results before the open of the market on Thursday, February 8, 2018. Tarek Sherif, chief executive officer, and Rouven Bergmann, chief financial officer,
Jan 11, 2018 11:00 am ET
Qlik Announces New CEO
Qlik®, a leader in data analytics, today announced that its board appointed Mike Capone, former COO of Medidata Solutions (NASDAQ:MDSO), as Qlik’s new CEO. Capone brings a valuable combination of customer perspective, operational expertise, and market focus to Qlik. In addition to his extensive experience in high-growth SaaS companies, Capone
Jan 09, 2018 08:30 am ET
Medical Research Collaborating Center Selects Medidata to Meet Global Regulatory Requirements During Clinical Trials
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that the
Jan 03, 2018 08:30 am ET
Medidata to Present at J.P. Morgan 36th Annual Healthcare Conference
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Rouven Bergmann, chief financial officer, will present at the J.P. Morgan 36th Annual Healthcare Conference on Thursday, January 11, at 8:00 a.m. PT (11:00 a.m. ET) in San Francisco.
Dec 13, 2017 08:43 am ET
New Quartesian Agreement with Medidata Expands Sponsor Access to the Medidata Clinical Cloud® during Clinical Trials
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, announced that Quar
Dec 06, 2017 08:30 am ET
Medidata SCA Wins Scrip Award for Best Technological Development in Clinical Trials - Sponsor Focused
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that the Medidata Synthetic Control Arm (SCA) was recognized at the 2017 Scrip Awards as the "Best Technological Development in Clinical Trials - Sponsor Focused." Out of the 15 other award catego
Dec 05, 2017 09:23 am ET
Medidata Expands Partnership with CytomX Therapeutics to Centralize Management of Regulated and Nonregulated Content
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that CytomX Therapeutics, Inc., a biopharmaceutical company developing investigational Probody™ therapeutics for the treatment of cancer, will expand its partnership to include Medidata
Dec 04, 2017 07:13 pm ET
Industry Survey Reveals Top 14 Technologies Necessary for a Unified eClinical Platform
Running a successful clinical trial or study is a complex and highly regulated process that requires vast operational expertise, a unified eClinical platform, and advanced statistical analytics. According to two global surveys conducted by Life Science Strategy Group in conjunction with
Nov 28, 2017 02:00 am ET
Medidata Presenting at the 2017 Partnerships in Clinical Trials Europe Conference
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced that Anthony Costello, vice president of mobile health, and Michael Hughes, lead product manager for payments at the Company, will speak at the 2017 Partnerships in Clinical Trials Europe (PCT) conference; which
Nov 22, 2017 08:05 am ET
Research Report Identifies Control4, Nevro, American Equity Investment Life Holding, Xperi, Spirit Aerosystems, and Medidata Solutions with Renewed Outlook — Fundamental Analysis, Calculating Forward
NEW YORK, Nov. 22, 2017 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Control4 Corporation (NASDAQ:CTRL), Nevro Corp. (NYSE:NVRO),...
Nov 21, 2017 08:30 am ET
Medidata to Present at Piper Jaffray Healthcare Conference
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the company’s participation in the 29th Annual Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017 in New York. Glen de Vries, co-founder and president, will participate on a panel
Nov 20, 2017 08:30 am ET
Global Medical Devices Company, MEL MEDICAL Enterprises, Modernizes Clinical Research with Multi-Year Medidata eTMF Agreement
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that
Nov 15, 2017 08:30 am ET
Medidata Selected by ICON to Evolve Image Management and Accelerate Research Goals for Sponsors and Sites During Clinical Trials
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, and ICON (NA
Nov 10, 2017 05:30 pm ET
Medidata Honors 2017 Architects of Hope Award Winners at Medidata NEXT Global
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the winners of the second annual Architects of Hope Awards. Four companies were recognized at the conclusion of the Medidata NEXT Global customer and partner conference.
Nov 09, 2017 08:30 am ET
Medidata Introduces New Strategic Monitoring Suite to Ensure Sponsors and Sites Meet ICH E6 Guidelines
Sites, Sponsors and CROs are facing increased costs and regulations in the area of monitoring. For studies conducted by CROs alone, monitoring accounts for nearly 50% of the cost of clinical trials - that's approximately $12 billion annually. In 2016, the International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use released guidelines, ICH E6 (R2) GCP, requiring sponsors to adopt a risk-based monitoring (RBM) framework, including statistical data quality checks. Today,
Nov 02, 2017 05:30 pm ET
Medidata to Host Financial Analyst Day on November 9 in New York City
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will host a Financial Analyst Day on Thursday, November 9, 2017 in New York City.
Nov 01, 2017 05:30 pm ET
Akros Pharma Inc. and Medidata Commemorate 10-year Partnership with Platform Expansion Agreement
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced today that Akros Pharma Inc. (“Akros”) has entered into an additional multi-year platform agreement, further expanding their 10-year old partnership to improve the efficiency and efficacy of their clinical tri
Oct 26, 2017 06:30 am ET
Medidata Reports Record Third Quarter 2017 Results
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced its financial results for the third quarter of 2017.
Oct 26, 2017 06:25 am ET
Horizon Pharma plc to Leverage Medidata Clinical Cloud® and eTMF Solutions to Support its Business Transformation
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that
Oct 19, 2017 09:09 am ET
Medidata Selected for Inaugural Fortune Future 50 List
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it has been selected for the Fortune Future 50 list; a ranking celebrating the world’s most forward-looking, innovative companies that are best set up for the future.
Oct 12, 2017 08:30 am ET
Medidata Schedules Third Quarter Earnings Conference Call for October 26, 2017
Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that it will release its third quarter 2017 financial results before the open of the market on Thursday, October 26, 2017. Tarek Sherif, chief executive officer, and Rouven Bergmann, chief financial officer, w
Oct 05, 2017 08:30 am ET
Neurological-Focused Pharmaceutical Company, Lundbeck, Continues Use of Medidata Clinical Cloud® with Multi-Year Partnership
Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that pharmaceutical firm
Jun 20, 2017 07:17 pm ET
Medidata Solutions Set to Join S&P MidCap 400; McDermott International to Join S&P SmallCap 600
NEW YORK, June 20, 2017 /PRNewswire/ -- S&P SmallCap 600 constituent Medidata Solutions Inc. (NASD: MDSO) will replace PrivateBancorp Inc. (NASD: PVTB) in the S&P MidCap 400, and McDermott International Inc. (NYSE: MDR) will replace Medidata Solutions in the S&P SmallCap 600 effective prior to the open on Monday, June 26. Canadian Imperial Bank of Commerce is acquiring PrivateBancorp in a deal expected to be completed on June 23.
Aug 30, 2016 08:30 am ET
SHYFT Analytics Raises $12.5 Million in New Funding From Global Healthcare and Technology Leaders, Led by McKesson Ventures and Medidata Solutions
SHYFT Analytics, a leader in cloud data and analytics for the global life sciences industry, today announced the company has secured an initial $12.5 million in Series B funding. SHYFT Management opted for an all strategic collaboration, which included investments from McKesson Ventures, Medidata Solutions (NASDAQ: MDSO) and other healthcare and technology industry leaders. SHYFT will use the investment to continue its rapid growth and expansion and further advance its leading healthcare cloud analytics platform. Existing investors, Health Enterprise Partners and Milestone Venture Partners,

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.